Phase II Study of Cediranib (AZD 2171), an Inhibitor of the Vascular Endothelial Growth Factor Receptor, for Second-Line Therapy of Small Cell Lung Cancer (National Cancer Institute #7097)
Ramalingam, Suresh S., Belani, Chandra P., Mack, Philip C., Vokes, Everett E., Longmate, Jeffrey, Govindan, Ramaswamy, Koczywas, Marianna, Ivy, S. Percy, Gandara, David R.Volume:
5
Language:
english
Journal:
Journal of Thoracic Oncology
DOI:
10.1097/JTO.0b013e3181e2fcb0
Date:
August, 2010
File:
PDF, 280 KB
english, 2010